NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

New HSE risks may include ‘second pandemic’

By Mindo - 24th Mar 2021

3D Rendering of planet Earth made to look like a virus cell.

A number of “new risks” have recently been considered as possible additions to the HSE corporate risk register (CRR), including vaccine roll-out, a “second pandemic”, data protection, and climate change. The updated risk register, approved by the HSE board at its December meeting, noted 26 risks. The majority were influenced by the Covid-19 pandemic.

The risk register was discussed by the HSE audit and risk committee at its meeting on 11 December. None of the ‘new risks’ discussed were subsequently added to the updated CRR approved by the HSE board later in the month.
According to minutes of the audit and risk committee meeting, seen by this newspaper following a Freedom of Information request, “new risks for consideration” for the risk register included “vaccine roll-out” and a “second pandemic risk”.

Regarding a “second pandemic”, it was noted that “this risk has been raised by the board and committees on a number of occasions. While there are a number of Covid risks on the CRR, this is a separate and independent risk in terms of probability (eg, emergence of a second pandemic of a different origin).”

The committee also discussed “data protection” as a potential addition, “including data retention risks with sensitive personal data, and risks related to contractual relationships with Genomics Ireland, for example.” According to minutes, “this class of risks are coming to the fore in recent times”.

The issues of “sustainability and climate change” were also referenced, with minutes noting that the HSE “should consider a plan to identify and address risks in this area”.

Leave a Reply

Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read